Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ligand Pharmaceuticals Inc (NASDAQ:LGND)

104.48
Delayed Data
As of Dec 09
 +0.85 / +0.82%
Today’s Change
82.06
Today|||52-Week Range
139.79
-3.63%
Year-to-Date
No recent news for Ligand Pharmaceuticals Inc.

Today’s Trading

Previous close103.63
Today’s open104.47
Day’s range103.28 - 107.56
Volume278,249
Average volume (3 months)399,142
Market cap$2.2B
Dividend yield--
Data as of 4:00pm ET, 12/09/2016

Growth & Valuation

Earnings growth (last year)+1,833.30%
Earnings growth (this year)+1.07%
Earnings growth (next 5 years)+40.00%
Revenue growth (last year)+11.43%
P/E ratio373.1
Price/Sales32.00
Price/Book8.71

Competitors

 Today’s
change
Today’s
% change
IRWDIronwood Pharmaceuti...+0.35+2.35%
AKRXAkorn Inc+0.20+1.09%
AGIOAgios Pharmaceutical...+1.72+3.59%
MDCOMedicines Co+2.03+6.19%
Data as of 4:14pm ET, 12/09/2016

Financials

Next reporting dateFebruary 15, 2017
EPS forecast (this quarter)$1.32
Annual revenue (last year)$71.9M
Annual profit (last year)$229.8M
Net profit margin319.58%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John L. Higgins
President &
Chief Operating Officer
Matthew W. Foehr
Corporate headquarters
La Jolla, California

Forecasts


Search for Jobs